A carregar...
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
This study investigated whether rosiglitazone may affect breast cancer risk in female patients with type 2 diabetes mellitus in Taiwan. The reimbursement database of all female patients with type 2 diabetes mellitus under oral antidiabetic agents or insulin from 1996 to 2009 was retrieved from the N...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356862/ https://ncbi.nlm.nih.gov/pubmed/27936468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13824 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|